SCHEMBL7648000

SCHEMBL7648000

C=C[CH]c1cccc2c1ccc1ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 4/20 0.54
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
CYP2A6 P11509 1/20 0.46
TSHR P16473 1/20 0.46
PAX8 Q06710 1/20 0.41
CYP1A2 P05177 3/20 0.40
HIF1A Q16665 2/20 0.40
HPGD P15428 2/20 0.40
CYP1B1 Q16678 1/20 0.40
THRB P10828 1/20 0.40
CYP3A4 P08684 2/20 0.38
LMNA P02545 2/20 0.38
MAPK1 P28482 2/20 0.38
MAPT P10636 1/20 0.38
APEX1 P27695 1/20 0.38
PMP22 Q01453 1/20 0.38
ERBB2 P04626 1/20 0.37
FYN P06241 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1389124 0.88 RXRA (0.44) ALDH1A1HSD17B10TDP1CYP2A6TSHR
SCHEMBL251216 0.88 RXRA (0.44) ALDH1A1HSD17B10TDP1CYP2A6TSHR
SCHEMBL28650536 0.87 HSD17B10 (0.50) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL2701066 0.84 HPRT1 (0.58) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL75829 0.84 HPRT1 (0.58) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL22288140 0.79 HPRT1 (0.64) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL5520716 0.77 BACE1 (0.41) ALDH1A1HSD17B10TDP1CYP2A6TSHR
Phenanthrene SCHEMBL2963532 0.76 ALDH1A1 (0.71) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL548120 0.76 HPRT1 (0.58) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL7896695 0.76 HPRT1 (0.58) HPRT1ALDH1A1HSD17B10TDP1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1251859-A1 NOVEL COMPOUNDS Xylogen AB (SE) 2002-10-30 EP disclosed
WO-2001054702-A1 NOVEL COMPOUNDS XYLOGEN AB (SE) 2001-08-02 WO disclosed